Correlation Between Atea Pharmaceuticals and Kronos Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Kronos Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Kronos Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Kronos Bio, you can compare the effects of market volatilities on Atea Pharmaceuticals and Kronos Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Kronos Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Kronos Bio.

Diversification Opportunities for Atea Pharmaceuticals and Kronos Bio

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Atea and Kronos is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Kronos Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kronos Bio and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Kronos Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kronos Bio has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Kronos Bio go up and down completely randomly.

Pair Corralation between Atea Pharmaceuticals and Kronos Bio

Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Kronos Bio. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 1.25 times less risky than Kronos Bio. The stock trades about -0.02 of its potential returns per unit of risk. The Kronos Bio is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  95.00  in Kronos Bio on September 26, 2024 and sell it today you would earn a total of  0.00  from holding Kronos Bio or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Atea Pharmaceuticals  vs.  Kronos Bio

 Performance 
       Timeline  
Atea Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Atea Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable forward indicators, Atea Pharmaceuticals is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Kronos Bio 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Kronos Bio are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Kronos Bio is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Atea Pharmaceuticals and Kronos Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Atea Pharmaceuticals and Kronos Bio

The main advantage of trading using opposite Atea Pharmaceuticals and Kronos Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Kronos Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will offset losses from the drop in Kronos Bio's long position.
The idea behind Atea Pharmaceuticals and Kronos Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.